Preprint Article Version 2 This version is not peer-reviewed

Synthesis and Activity Against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives

Version 1 : Received: 30 April 2018 / Approved: 2 May 2018 / Online: 2 May 2018 (12:54:38 CEST)
Version 2 : Received: 31 May 2018 / Approved: 1 June 2018 / Online: 1 June 2018 (09:39:56 CEST)

A peer-reviewed article of this Preprint also exists.

Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402. Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402.

Journal reference: Molecules 2018, 23, 1402
DOI: 10.3390/molecules23061402

Abstract

The tetracyclic pyrido[4,3-b]carbazole olivacine and four of its oxygenated derivatives have been synthesized by a late-stage palladium-catalyzed Heck-type cyclization of the pyrrole ring as key step. In a test for inhibition of the growth of Mycobacterium tuberculosis 9-methoxyolivacine showed the most significant inhibiting activity against Mycobacterium tuberculosis with an MIC90 value of 1.5 μM.

Subject Areas

inhibiting activity; catalysis; cyclization; olivacine; palladium; pyrido[4,3-b]carbazoles

Readers' Comments and Ratings (0)

Leave a public comment
Send a private comment to the author(s)
Rate this article
Views 0
Downloads 0
Comments 0
Metrics 0
Leave a public comment

×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.